Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Amazon box
June 12, 2026 Jeff Cross

Out-Recruiting the Giants: A Cleaning Company’s Edge in the Labor War

June 11, 2026

3 Ways to Use Less & Save More When Using Wiping Products

June 10, 2026 Andrew Navarro

Expand Your Services, Not Your Client Base

Sponsored Articles

3 Ways to Use Less & Save More When Using Wiping Products
June 11, 2026

3 Ways to Use Less & Save More When Using Wiping Products

May 18, 2026 Sponsored by Novonesis

From the Lab to the Reprocessing Floor: How Enzymatic Detergents Get Tested, Chosen, and Trusted

May 18, 2026 Sponsored by Novonesis

Where Cleaning Contracts Are Really Won or Lost

Recent News

Dan Smolensky and Mike Fitts

State of the Industry Shows Tension in Facility Upkeep

Lab-grown Bacteria Cures C. diff-caused Diarrhea

Health Officials Test Wastewater for Pathogens at World Cup